An analyst at Monness, Crespi, Hardt downgraded shares of Momenta Pharmaceuticals from Buy to Neutral in an intraday note today. The stock dipped in mid-day trading as the downgrade began hitting wires, however shares seem to be bouncing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.